The DOvEEgene Project
DOvEEgene is a research program focused on the early detection of ovarian and endometrial cancers through a genomic test. Developed by a team of Canadian doctors, professors, and researchers, the DOvEEgene test identifies cancer as early as stage 1, significantly improving upon current methods that often detect cancer in stages 3 or 4. The test analyzes DNA changes using an AI algorithm to distinguish between cancerous and non-cancerous cells, offering a more accurate screening than conventional methods. The program is actively recruiting participants for its clinical study, which is funded by Genome Canada, Genome Quebec, and the MUHC Foundation, making participation free of charge for eligible individuals.
The DOvEEgene Project
DOvEEgene is a research program focused on the early detection of ovarian and endometrial cancers through a genomic test. Developed by a team of Canadian doctors, professors, and researchers, the DOvEEgene test identifies cancer as early as stage 1, significantly improving upon current methods that often detect cancer in stages 3 or 4. The test analyzes DNA changes using an AI algorithm to distinguish between cancerous and non-cancerous cells, offering a more accurate screening than conventional methods. The program is actively recruiting participants for its clinical study, which is funded by Genome Canada, Genome Quebec, and the MUHC Foundation, making participation free of charge for eligible individuals.